Introduction
FMRFamide is a member of a family of neuropeptides first discovered in mollusks, but is known to be present across the animal phyla [1] . In mammals, a gene has been described that encodes to RF-amides, namely, neuropeptide FF and neuropeptide AF [2] . We recently found that mast cells express this neuropeptide FF gene, and may be source of RF-amides during allergic reactions [3] . RF-amides can effectively stimulate several mas-related gene protein receptors (Mrgprs), a family of G proteincoupled receptors selectively expressed on small-diameter nociceptive sensory neurons [4] . Considered together, these observations led to the hypothesis that RF-amides may be mediators in mast cell-sensory nerve interactions associated with allergic disease.
There has been little attention given, however, to the effect of RF-amides on primary afferent neurons in general and vagal afferent neurons in particular. RF-amides may directly modulate primary afferent neuronal activity is supported by the recent observation that RF-amides, including FMRFamide and neuropeptide FF, can enhance the acid-induced activation of acid-sensing ion channels (ASIC) in isolated dorsal root ganglion neurons [5] . RF-amides also evoke strong action potential discharge in an ex-vivo skin afferent nerve preparation, most notably in nociceptive C fibers [6] . This effect, however, does not appear to be secondary to ASIC channel activation.
Subcutaneous injection of FMRFamide into rat paws leads to nociceptive or algogenic behaviors, and intravenous injection has profound cardiorespiratory effects [6] [7] [8] . The algogenic behavior to peripheral RF-amide treatment is likely explained by activation of dorsal root ganglia (DRG) C fibers. The increase in blood pressure may be due to stimulation of naloxone-sensitive receptors in the central nervous system [8] . In addition, we hypothesized that some of the cardiopulmonary effects may be secondary to similar activity in the vagal sensory system. For example, RF-amides, including FMRFamide causes apnea followed by a depression in respiratory rate; an effect commonly associated with stimulation of certain vagal C fiber afferent neurons [9] .
Vagal afferent neurons are situated in the nodose and jugular ganglia. These ganglia are anatomically, embryologically, and functionally distinguished from each other, and are inferred to contribute distinctly to pathophysiology of diseases [10] . In this study, we aimed to see the direct effect of RFamide on vagal afferent nodose and jugular neurons.
Methods
The Hartley guinea pigs (300-400 g) were used and killed using CO 2 . The jugular and nodose ganglia were harvested and incubated in the enzyme buffer (2 mg/ml of collagenase and 2 mg/ml of dispase II dissolved in Ca For intracellular calcium measurements, the neurons were loaded with Fura-2 AM (Invitrogen, Carlsbad, California, USA) and then, 20 min before experiment, superfused by infusion pump (8 ml/min) with 351C Locke buffer: NaCl (136 mM); KCl (5.6 mM); MgCl 2 (1.2 mM); CaCl 2 (2.2 mM); NaH 2 PO 4 (1.2 mM); NaHCO 3 (14.3 mM); and dextrose (10 mM; pH, 7.3-7.4). Intracellular calcium measurements were taken under a microscope equipped for epifluorescence. A field of cells was monitored by sequential dual excitation (352 and 380 nm) and ratios of the images were converted to calcium concentration according to methods and parameters presented previously [11] . The ratio images were acquired every 6 s.
The neurons were considered to have responded to FMRFamide (1 mM, for 1 min) if the drug-induced peak increase was greater than 3 Â standard deviation of baseline intracellular Ca 2+ concentration.
To check capsaicin sensitivity of tested neurons, capsaicin (1 mM, for 20 s) was applied to the neurons in the end of each experiment.
Gramicidin-perforated, whole-cell, patch-clamp recordings were done in jugular and nodose neurons. A pipette (1.5-3 MO) was filled with pipette solution composed of the following: KCl 140 mM; CaCl 2 1 mM; MgCl 2 2 mM; ethyleneglycol-bis-(b-aminoethyl ether)-N,N 0 -tetraacetic acid 11 mM; dextrose 10 mM; titrated to pH 7.3 with KOH; 304 mOsm. Gramicidin was dissolved in dimethyl sulfoxide and mixed into the pipette solution to a final concentration of 1 mg/ml just before each recording. During the experiments, the cells were continuously superfused (6 ml/min) by gravity with Locke solution. All recordings were taken at 351C. The membrane potential of the cells was held at -60 mV.
FMRFamide (Sigma, St. Louis, Missouri, USA) and capsaicin (Sigma) were dissolved in distilled water and ethanol at the concentration of 10 mM, respectively. Drugs were diluted with Locke solution at final concentration of 1 mM before each experiment. Data were expressed as means ± standard error of the mean. A Student t-test and the w 2 -test were used when appropriate.
Results

Intracellular calcium measurement
We evaluated 128 neurons vagal sensory neurons isolated from nodose and jugular ganglia. RFamide caused a brisk elevation in intracellular calcium in both nodose and jugular neurons, which usually started within 30 s of FMRFamide application and almost returned to baseline within 5 min. There was, however, significant difference in the propensity of FMRFamide to stimulate nodose versus jugular neurons (Table 1 ; P < 0.05). FMRFamide (1 mM) stimulated the vast majority (85%) of nodose neurons (n = 73). In contrast, it stimulated calcium increases in only 40% of the jugular neurons (n = 55).
FMRFamide responsiveness did not differentiate between capsaicin-sensitive and capsaicin-insensitive neurons. FMRFamide stimulated 49 of 71 (69%) of capsaicinsensitive neurons and 35 of 57 (61%) capsaicin-insensitive neurons ( Table 2) .
Patch-clamp recordings
When vagal afferent neurons were studied in currentclamp mode, FMRFamide evoked a membrane depolarization. In concordance with better responsiveness of nodose neurons in intracellular calcium assay, the amount of membrane depolarization observed in nodose neurons was greater than that observed in jugular neurons. The membrane depolarizations averaged 10.3 ± 2.6 mV (ranged from 0 to 21.0 mV) and 4.6 ± 1.7 mV (ranged from -5.6 to 15.3 mV) in nodose and jugular ganglionic neurons, respectively. Nevertheless, in 50% of both the nodose and jugular neurons, the membrane depolarization reached the threshold for action potential discharge (Fig. 1a and b, filled circles) .
To get some idea of the nature of the currents leading to the membrane depolarization, we measured changes in membrane current passing through the cellular membrane in voltage clamp mode. We found that the inward current induced by FMRFamide was associated with an increase in membrane conductance (Fig. 2a) . If there was no current rectification, the calculated reversal potential was approximately + 33.3 mV (Fig. 2b) .
Discussion
The results demonstrate that FMRFamide can directly cause membrane depolarization and action potential discharge in vagal afferent neurons. The gap between resting membrane potential and the threshold for action potential seemed to be bigger in nodose neurons than the one in jugular neurons; therefore, nodose neurons might need more depolarization than jugular neurons did to discharge action potential. In this study, the probabilities of action potential discharge by FMRFamide application were same in both nodose and jugular neurons despite that nodose neurons depolarized more than jugular neurons did. The membrane depolarization was associated with the opening of undetermined cation channels. The overt activation and action potential discharge evoked by FMRFamide may explain some of the physiological effects of RF-amides in mammals. For example, RF-amides such as FMRFamide can cause apneas followed by a decrease in the rate and increase in the depth of respiration. This is precisely the pattern observed upon activation of guinea pig jugular C fibers in the lungs [9] .
The nodose and jugular neurons have distinct pharmacological profiles. Nodose neurons have been known to be more sensitive to several inflammatory mediators in tissue such as histamine, serotonin, ATP, and adenosine than jugular neurons [10, [12] [13] [14] . In this study, nodose neurons were also more sensitive to FMRFamide. Together with the probability of action potential discharge, the nodose neurons may have more receptors responding to FMRFamide, but quite a number of nodose neurons failed to make action potential discharge due to a relatively big gap between resting membrane potential and threshold for action potential. It was possible that the neurons, which failed to discharge action potential were sensitized to respond to other stimuli.
Although we show that RF-amides can directly activate vagal afferent neurons, the mechanism underlying this effect is not known. FMRFamide is an effective agonist at several Mrgprs, and they are expressed in vagal afferent neurons. Mrgprs may be G q -coupled receptors, and these Table 2 FMRFamide sensitivity in capsaicin-sensitive and capsaicin-insensitive neurons of vagal ganglia in intracellular calcium measurements Patch-clamp recordings in nodose and jugular ganglia. Membrane depolarization and action potential discharge were induced by FMRFamide application in isolated neurons from jugular and nodose ganglia (a). The average of amplitude of membrane depolarization was bigger in nodose (n = 10) than jugular (n = 10) ganglionic neurons, but induction probability of action potential was the same 50% in both ganglionic neurons (b). Filled circle and opened rhombus indicate presence and absence of action potential discharge, respectively. Vagal afferent activation by FMRFamide Lee et al. 611 receptors are known to be capable of gating TRPV1 channels. It is unlikely, however, that TRPV1 is obligatory for the FMRFamide-induced responses, as FMRFamide was effective in stimulating many capsaicin-insensitive neurons. G q -coupled receptors can also excite isolated sensory neurons by an inhibition of Kv7 M currents [15] . It is unlikely that FMRFamide-induced membrane depolarization was due to inhibition of a resting potassium current, as it was associated with an increase in conductance of ions with a reversal potential of approximately + 30 mV. In addition to Mrgprs, RF-amides are agonists of at least two other G protein-coupled receptors, termed FF1 and FF2 [16] . Although vagal ganglia were not studied, these investigators identified mRNA expression for both FF1 and FF2 in DRG neurons. At present, there are no useful pharmacological tools with which to evaluate the potential roles of FF1, FF2, or certain Mrgprs in the guinea pig.
We used the concentration of 1 mM of FMRFamide in this study because Mrgprs [4] , FF1, and FF2 [16] have fully responded to it in this concentration. In higher concentration, FMRFamide could affect the neurons in some uncertain way. In addition to G-protein-coupled receptor mechanisms, RFamides may lead to stimulation of afferent neurons independently of G-protein-coupled receptors by sensitization of certain ASIC in isolated DRG neurons, but FMRFamide did not evoke an overt inward current at normal pH in that study [5] . It is unlikely that the inward currents and membrane depolarizations, we observed in vagal afferent neurons at neutral pH, is explained by sensitizing effects on acid-sensing channels.
The activation of mast cells leads to symptoms and behaviors consistent with afferent nerve activation, including itching, sneezing, coughing, and reflex effects in the respiratory and gastrointestinal tracts [17] . Recently, we have reported that Mrgpr C11 receptors were activated by a product of IgE-dependent stimulation of mast cells. Although the Mrgpr C11 activating product was not definitively identified, circumstantial evidence favored a RF-amide as one likely candidate [3] . The observation here with vagal afferent neurons, along with observations showing that RF-amide can stimulate action potential discharge in DRG C fibers innervating the skin, support the hypothesis that RF-amides may be relevant mediators in mast cell-sensory nerve activation in both the somatosensory and vagal-visceral systems.
Conclusion
We showed that FMRFamide directly activated the vagal sensory nerves by opening cation channels. The increase of intracellular calcium and the amount of membrane depolarization responded to FMRFamide were higher in nodose ganglionic vagal nerves than jugular ones. But probabilities of action potential discharge were same in both nerves.
